In an article titled “FDA approves higher dose brigatinib tablet for advanced ALK+ NSCLC,” published October 3, 2017, the previously available tablet size was misstated. Only 30 mg brigatinib (Alunbrig) tablets were available previously.
In an article titled “FDA approves higher dose brigatinib tablet for advanced ALK+ NSCLC,” published October 3, 2017, the previously available tablet size was misstated. Only 30 mg brigatinib (Alunbrig) tablets were available previously.